Pharmaids Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
PHARMAID
Pharmaceuticals
Screen Pharmaids Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹47.81
▲
2.17 (4.75%)
Market Cap
₹176.36 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.40
EPS (TTM)
₹-3.05
Dividend Yield
-
Debt to Equity
0.36
52W High
₹81.65
52W Low
₹44.08
Operating Margin
-82.00%
Profit Margin
-100.00%
Revenue (TTM)
₹5.00
EBITDA
₹-4.00
Net Income
₹-5.00
Total Assets
₹120.00
Total Equity
₹55.00
Pharmaids Pharmaceuticals Share Price History - Stock Screener Chart
Screen PHARMAID historical share price movements with interactive charts. Analyze price trends and patterns.
Pharmaids Pharmaceuticals Company Profile - Fundamental Screener
Screen Pharmaids Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PHARMAID shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE117D01018
Pharmaids Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen PHARMAID balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 120 | 91 | 25 | 11 |
| Current Assets | 22 | 14 | 18 | 3 |
| Fixed Assets | 77 | 63 | 0 | 0 |
| Liabilities | ||||
| Total Liabilities | 120 | 91 | 25 | 11 |
| Current Liabilities | 36 | 9 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 55 | 71 | 23 | 9 |
| Share Capital | 35 | 35 | 21 | 10 |
| Reserves & Surplus | 24 | 37 | 1 | -2 |
Screen PHARMAID income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 7 | 12 | 6 | 5 | 5 | 5 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Expenses | 9 | 12 | 14 | 11 | 8 | 8 | 8 | 9 | 2 | 2 | 1 | 3 | 0 | 1 | 1 |
| EBITDA | -4 | -5 | -2 | -6 | -4 | -2 | -3 | -9 | -1 | -1 | -1 | -2 | 0 | -1 | -1 |
| Operating Profit % | -82.00% | -81.00% | -62.00% | -96.00% | -74.00% | -46.00% | -62.00% | 0.00% | 0.00% | 0.00% | 0.00% | -12200.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -5 | -7 | -4 | -7 | -4 | -3 | -4 | -9 | -1 | -1 | -1 | -2 | 0 | -1 | -1 |
| Tax | -1 | -2 | -1 | -1 | -1 | -1 | -1 | -2 | 0 | 0 | -1 | -1 | 0 | 0 | 0 |
| Net Profit | -5 | -5 | -3 | -6 | -3 | -2 | -3 | -6 | -1 | -1 | -1 | -1 | 0 | -1 | -1 |
| EPS | -1.11 | -1.39 | -0.70 | -2.82 | -0.76 | -0.73 | -0.55 | -4.76 | -0.61 | -0.61 | -0.24 | -0.54 | 0.00 | -0.05 | -0.54 |
Pharmaids Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen PHARMAID cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -14 | -11 | -4 | 0 |
| Investing Activities | -12 | -75 | -5 | 1 |
| Financing Activities | 23 | 78 | 21 | 0 |
| Net Cash Flow | -3 | -8 | 12 | 0 |
Screen PHARMAID shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Apr | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 5.22% | 5.14% | 32.99% | 5.64% | 5.64% | 5.56% | 5.19% | 5.22% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 36.59% | 36.35% | 47.02% | 41.06% | 41.06% | 41.14% | 41.03% | 36.42% |
| Other Holding | 58.20% | 58.51% | 19.99% | 53.30% | 53.30% | 53.29% | 53.78% | 58.37% |
| Shareholder Count | 8,220 | 8,026 | 8,027 | 7,554 | 7,567 | 7,594 | 8,050 | 8,349 |
Pharmaids Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen PHARMAID dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Pharmaids Pharmaceuticals Index Membership - Market Screener Classification
Screen PHARMAID by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Pharmaids Pharmaceuticals Market Events Screener - Corporate Actions
Screen PHARMAID market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -12.02% | ||
| Annual General Meeting | NA | -4.35% | ||
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 0.44% |
| 2025-08-21 | 2025-08-21 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 0.43% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | -0.31% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.19% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 21.50% |
| 2024-01-31 | 2024-01-31 | Extraordinary General Meeting | NA | -1.74% |
| 2022-12-31 | 2022-12-31 | Extraordinary General Meeting | NA | 47.76% |
Pharmaids Pharmaceuticals Competitors Screener - Peer Comparison
Screen PHARMAID competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Pharmaids Pharmaceuticals Company Announcements - News Screener
Screen PHARMAID latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-30 | Re-Lodgment Of Requests For Transfer Of Physical Shares | View |
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-29 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-28 | Outcome Of The Circular Resolution Dated 28Th November 2025. | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Re-Lodgement Of Requests For Transfer Of Physical Shares | View |
| 2025-11-11 | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-11-06 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-15 | Re-Lodgement Of Requests For Transfer Of Physical Shares | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-24 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-24 | Intimation Under Regulation 31A(10)(Ii) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Reclassification Of Promoter(S) Pursuant To The Open Offer Under SEBI (SAST) Regulations 2011. | View |
| 2025-09-23 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-18 | Announcement under Regulation 30 (LODR)-Diversification / Disinvestment | View |
| 2025-09-06 | Announcement Under Regulation 30 - Intimation Of Registration Of Sale Deed. | View |